The largest database of trusted experimental protocols

8 protocols using superdex 200 resin

1

NIRF Macrophage Targeting Probe Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The NIRF probe targeting CD68+ macrophages was generated by coupling an amine-reactive NIR fluorochrome (NHS ester), VivoTag 680 (excitation peak 665 ± 5 nm, emission peak 688 ± 5 nm) (Perkin-Elmer), to a rat anti-mouse CD68 antibody (AbDSerotec) according to manufacturer’s instructions. In brief, VivoTag 680 was dissolved in dry dimethyl sulfoxide (Sigma-Aldrich) at a concentration of 10 mg/ml. Prior to the labeling, the buffer of the antibody was exchanged by dialysis into conjugation buffer (50 mM carbonate/bicarbonate buffer, pH 8.5) using Slide-A-Lyzer dialysis cassettes (AbD Serotec) according to the protocol provided by the manufacturer. After buffer exchange, 30 μl of VivoTag 680 was added to the rat anti-mouse CD68 antibody. Following 1 h of incubation at room temperature protected from the light, the NIRF CD68 probe (approximately 151 kDa) was separated from free fluorescent dye (approximately 1 kDa) and antibody oligomers (larger than 300 kDa) by fast protein liquid chromatography using a Superdex 200 resin in a pre-packed 10/300 GL column (GE Healthcare). Probe concentration was determined using a BCA Protein Assay Kit (Uptima) according to the protocol provided by the manufacturer.
+ Open protocol
+ Expand
2

Characterizing Core-Shell Silica Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gel permeation chromatography (GPC) served as a preparative and analytical tool to monitor the dispersity of a particle reaction. Based on different elution times of different species in the reaction mixture, the core-shell silica nanoparticles can be separated from unreacted precursors or PEG aggregates (see Results and Discussion). A BioLogic LP system equipped with a 275 nm UV detector was used. The stationary phase was a Superdex 200 resin (GE Healthcare) in a 2 cm x 20 cm glass column operated at a flow rate of 2 mL/min. The mobile phase was a 5% (w/v) sodium chloride aqueous solution. Particle concentrations were increased with a spin-filter (GE healthcare Vivaspin, 30k MWCO) before sample loading. Typical injection volumes were 500 to 600 μL. Fractions at different elution times were collected by a BioFrac fraction collector. For long time storage, all particles were transferred to DI water using a spin-filter by exchanging solvent at least five times.
+ Open protocol
+ Expand
3

Purification and Characterization of RelA

Check if the same lab product or an alternative is used in the 5 most similar protocols
DTT, BSA and antibiotics were purchased from Melford Laboratories; polyacrylamide-bis polyacrylamide [30% (w/v), 37:5:1], Bacto tryptone and yeast extract for culture media were purchased from Oxoid. Chelating fast flow resin and Superdex 200 resin were purchased from GE Healthcare; primers were purchased from Eurofins; restriction enzymes and E. coli strain K12 JM109 were purchased from New England Biolabs; pET16b plasmid was purchased from Merck Chemicals; E. coli RelA was expressed using a strain from the ASKA Clone library purchased from Shigen; E. coli MRE600 (C6) strain was purchased from NCTC. Francisella philomiragia was obtained from A.T.C.C.; mRNA was purchased from ATDBio. Unless stated otherwise all other reagents were purchased from Sigma–Aldrich or Fisher Scientific. Graphpad Prism version 6 for Windows was obtained from Graphpad Software.
+ Open protocol
+ Expand
4

Protein Purification by GPC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Soluble protein was filtered through a 0.22 μm syringe filter to remove large particles and injected into a 500 μL sample loop, prior to fractionation by gel permeation chromatography (GPC) using Superdex 200 resin packed in a 10/300 column connected to an ÄKTATM prime plus chromatography system (GE Healthcare, Chicago, IL, USA). The column was routinely calibrated using commercial gel filtration calibration kits from 75 to 669 kDa (GE Healthcare, USA) and equilibrated with 10 mM HEPES-KOH, pH 7.5, 100 mM NaCl, at a flow rate of 0.4 mL min−1. Fractions of 0.8 mL were collected when elution volume was 6.6 mL and concentrated 10-fold using an Amicon Ultra 30K centrifugal filter unit (Merck Millipore, Darmstadt, Germany). Concentrated samples were further supplemented with SDS–PAGE sample loading buffer (Beyotime Biotechnology, Haimen, China) following the manufacturer’s instructions before SDS-PAGE and Western blotting.
+ Open protocol
+ Expand
5

Purification and Characterization of β-Glucosidase

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lyophilized β-glucosidase from sweet almonds, buffers, and p-nitrophenyl-β-d-glucopyranoside (PNPGluc) were obtained from Sigma-Aldrich (St. Louis, MO, USA). Pre-packed HiTrap-Q anion exchange column, and Superdex 200 resin were from GE Healthcare Life Sciences (Piscataway, NJ, USA). Electrophoresis reagents of high purity were purchased from Bio-Rad (Hercules, CA, USA).
+ Open protocol
+ Expand
6

Purification and Characterization of FDH Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
The primers for active site variants were prepared by Integrated DNA Technologies. QuikChange II Site-Directed Mutagenesis Kits were purchased from Agilent Technologies. E. coli BL21 (DE3) pLysS cells were from Novagen. Blue sepharose 6 fast flow and Superdex 200 resin were from GE Healthcare Life Sciences. Bradford dye reagent, SDS gels and the protein standards were from Bio-Rad. [Ad-14C]-NAD+ was from PerkinElmer. [3H]- formic acid was from Moravek Biochemicals. All other materials were purchased from Sigma-Aldrich unless otherwise specified.
Site directed mutagenesis was performed on the gene for WT FDH, using standard procedures, and the primer design is listed in the SI. Plasmids were transformed into BL21 (DE3) pLysS cells and grown in 6 L Luria-Bertani medium with 100 mg/L ampicillin at 37°C and 250 rpm. Expression and purification of WT and variant FDHs were carried out using the procedure in Ref. 29 (link).
+ Open protocol
+ Expand
7

Protein Extraction and Fractionation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples used for native-PAGE activity staining were extracted from three developing endosperms at 10 to 15 days after flowering following the methods of Miura et al.16) (link)
Soluble protein (SP), loosely-bound protein (LBP) and tightly-bound protein (TBP) fractions were extracted from three developing endosperms as described by Fujita et al.20) (link) Western blotting was performed as described previously.21) (link)
A 700 mg aliquot of developing endosperms was extracted and fractionated by gel filtration chromatography using Superdex 200 resin packed in a XK16 column (16/400, GE Healthcare, Chicago, IL, USA) according to Crofts et al.13) (link) Western blotting following native-PAGE was performed as described in Crofts et al.,13) (link) and Miura et al.16) (link)
+ Open protocol
+ Expand
8

Formate Dehydrogenase Purification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pET-23a plasmid harboring the gene encoding for CbFDH was a generous gift from Dr. Nikolaos Labrou of the Agricultural University of Athens. E. coli BL21 (DE3) pLysS cells were from Novagen. Blue sepharose 6 fast flow and Superdex 200 resin were from GE Healthcare Life Sciences. Bradford dye reagent, immobilized pH gradient (IPG) strips for isoelectric focusing (IEF), SDS gels and the protein standards were from Bio-Rad. [Ad-14C]-NAD+ was from PerkinElmer. [3H]-formic acid was from Moravek Biochemicals. All other materials were purchased from Sigma-Aldrich unless otherwise specified.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!